help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y.-K.
Right arrow Articles by Denburg, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.-K.
Right arrow Articles by Denburg, J. A.

Am. J. Respir. Cell Mol. Biol., Volume 20, Number 3, March, 1999 388-397

Immunolocalization of CD34 in Nasal Polyposis
Effect of Topical Corticosteroids

Young-Ki Kim,* Masashi Uno,* Daniel L. Hamilos, Lisa Beck, Bruce Bochner, Robert Schleimer, and Judah A. Denburg

Department of Otolaryngology, Inje University, Seoul, Korea; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Washington University School of Medicine, St. Louis, Missouri; and Johns Hopkins Allergy and Asthma Research Center, Baltimore, Maryland

Airway inflammation in patients with nasal polyps is characterized by the increased presence of eosinophils, the numbers of which are reduced after treatment with topical corticosteroids. Because eosinophilic responses in the airways are in part due to eosinophil progenitor differentiation, we hypothesized that CD34, a cell surface, sialomucinlike glycoprotein that specifically marks hemopoietic progenitors and endothelium, would be expressed in nasal polyp tissue. We sought to identify CD34+ leukocytes or endothelial cells in nasal polyps. We also investigated the effect of the topical corticosteroid budesonide on the numbers of CD34+ cells and vessels in nasal polyps. To accomplish this, we performed immunostaining for CD34 protein in tissue sections of nasal polyps from topical steroid-treated and -untreated groups of patients, as well as from one patient before and after systemic corticosteroid therapy. We also examined myeloid colony formation by isolated polyp mononuclear cells, and performed flow cytometry to detect the presence of CD34+/CD45+ cells within these isolated populations. We also examined the in vitro effects of steroids on human umbilical vein endothelial cell (HUVEC) expression of CD34. We detected CD34-immunoreactive mononuclear cells and blood vessels in the lamina propria of all nasal polyps. CD34+ mononuclear cells resembled immature hemopoietic cells morphologically. Mononuclear cell fractions from polyps contained myeloid colony-forming cells and cells bearing CD45, a pan-leukocyte marker, as well as CD34, and gated as true hemopoietic blast cells. The numbers of CD34+ cells and CD34+ vessels in steroid-treated nasal polyps were significantly higher than in steroid-untreated nasal polyps (15.67 ± 2.08 cells/10 hpf, versus 5.33 ± 1.36 cells/10 hpf, P = 0.002; 101.25 ± 6.24 vessels/0.5 mm2 of lamina propria, versus 57.22 ± 8.00 vessels/0.5 mm2 of lamina propria, P = 0.0008, respectively). A similar upregulation of CD34 immunostaining, especially for mononuclear cells, was observed in one patient after systemic corticosteroid therapy. Steroid treatment in vitro of HUVECs did not result in enhanced CD34 expression. Both CD34+/CD45+ mononuclear cells and CD34+ endothelial cells are present within nasal polyps, with higher numbers in patients who have received topical corticosteroid treatment. Because enhancement of CD34 expression was not seen in cultured umbilical vein endothelial cells treated in vitro with corticosteroid, the findings of the study suggest that in nasal polyp tissue, steroids enhance numbers of CD34+ progenitors and endothelial cells via indirect mechanisms.


* Drs. Kim and Uno contributed equally to this manuscript.




This article has been cited by other articles:


Home page
Eur Respir JHome page
J. A. Denburg and S. F. van Eeden
Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology.
Eur. Respir. J., March 1, 2006; 27(3): 441 - 445.
[Full Text] [PDF]


Home page
BloodHome page
T. S. Hallstrand, J. D. Sprenger, J. M. Agosti, G. M. Longton, R. P. Witherspoon, and W. R. Henderson Jr
Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors
Blood, November 15, 2004; 104(10): 3086 - 3090.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. C. Dorman, A. Efthimiadis, I. Babirad, R. M. Watson, J. A. Denburg, F. E. Hargreave, P. M. O'Byrne, and R. Sehmi
Sputum CD34+IL-5R{alpha}+ Cells Increase after Allergen: Evidence for In Situ Eosinophilopoiesis
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Shen, P. M. O'Byrne, R. Ellis, J. Wattie, C. Tang, and M. D. Inman
The Effects of Intranasal Budesonide on Allergen-induced Production of Interleukin-5 and Eotaxin, Airways, Blood, and Bone Marrow Eosinophilia, and Eosinophil Progenitor Expansion in Sensitized Mice
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 146 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Saito, K. Matsumoto, A. E. Denburg, L. Crawford, R. Ellis, M. D. Inman, R. Sehmi, K. Takatsu, K. I. Matthaei, and J. A. Denburg
Pathogenesis of Murine Experimental Allergic Rhinitis: A Study of Local and Systemic Consequences of IL-5 Deficiency
J. Immunol., March 15, 2002; 168(6): 3017 - 3023.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. M. GAUVREAU, L. J. WOOD, R. SEHMI, R. M. WATSON, S. C. DORMAN, R. P. SCHLEIMER, J. A. DENBURG, and P. M. O'BYRNE
The Effects of Inhaled Budesonide on Circulating Eosinophil Progenitors and Their Expression of Cytokines after Allergen Challenge in Subjects with Atopic Asthma
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2139 - 2144.
[Abstract] [Full Text]


Home page
ThoraxHome page
J. A Denburg
Haemopoietic mechanisms in nasal polyposis and asthma
Thorax, October 1, 2000; 55(90002): 24S - 25.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1999 American Thoracic Society.
  Tobacco